A Regulatory Perspective: Integrating PIM into the Product Lifecycle

Add bookmark

A Regulatory Perspective: Integrating PIM into the Product Lifecycle

Add bookmark

Helen Winsor from Pharma IQ, speaks to Dr. Andrew Marr, Director of e-Regulatory Development and Global Regulatory Operations and Co-Chair of the PIM Steering Committee on behalf of the EFPIA.  In this interview, he addresses the latest developments in Project Information Management (PIM) and gives an overview of why it is important to prepare before implementing PIM. Dr. Marr also outlines the main challenges faced and the lessons learned so far by trial groups – and talks in depth about the advantages to be gained from implementation. Haven’t got the technology to listen to the podcast? Download the transcript here:What next for PIM and Lifecycle Management?

[inlinead]


Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended